Tables
Eos ≤ 2% (n=74) Eos > 2% (n=16) p-value FEV1 %pred 42.2±18.1 49.8±15.7 0.10 Inhalation corticosteroids (CS) 66(89%) 11 (69%) 0.05 Pretreatment systemic CS 35(47%) 7 (44%) 0.80 Exacerbations last 2 years 3.7±3.8 2.5±2.4 0.34 CRP mg/l 55.4±68.6 39.5±63.2 0.17 Treatment failure ≤ day 30 33 (44.6%) 6 (37.5%) 0.60 Time to treatment failure(days) 53.54±79.25 55.27±61.33 0.19 Lenght of Stay (LOS) (days) 8.69±6.00 6.00±2.28 0.03 Mortality 4 (5.4%) 1(6.3%) 0.46
Vol 42 Issue Suppl 57
Table of Contents
Eosinophilia as marker of outcome in hospitalised patients with AECOPD
